Regulation of CD8+ T cell responses via liver NK-DC crosstalk
Regulation of CD8+ T cell responses via liver NK-DC crosstalk
批准号:
8282807
负责人:
Young S. Hahn
金额:
$25.86万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
Adenovirus InfectionsAdenovirusesAffectAntigensAntiviral AgentsBiological ModelsBone MarrowCD8B1 geneCell physiologyCellsChimera organismCoupledFailureGenerationsGoalsHepatitis C virusHepatocyteIL2RA geneImmuneImmune responseImmunityImmunizationImmunotherapeutic agentImpairmentInfectionInjection of therapeutic agentInjuryInterferonsInterleukin-10LacZ GenesLinkLiverMediatingModelingMusNatural ImmunityNatural Killer CellsPhasePlayPoly I-CRecruitment ActivityRegulationReporterReportingRoleRouteSignal TransductionSiteSystemT cell regulationT cell responseT-Cell ActivationT-LymphocyteTNFRSF5 geneTestingTherapeutic AgentsTissuesViral AntigensVirusVirus Diseasesadaptive immunitybasecell typecytokinedesignfood antigenin vivoinsightintrahepaticliver functionliver infectionlymph nodesreceptor
中文摘要
肝脏演变机制(S),以抑制和可能抑制宿主对非致病食物的免疫
抗原。因此,嗜肝病毒如丙型肝炎病毒在肝脏中建立了持续的感染
CD8+T细胞反应受损。NK细胞在肝脏中高度丰富,对病毒具有天然的防御作用。
感染。NK细胞与靶细胞结合后,NK细胞被激活并表达NK
激活/抑制受体以激活NK活性。NK细胞亲密相互作用的信号转导
激活/抑制受体是控制NK活性的关键。据报道,NK细胞扮演着一种
先天免疫与获得性免疫的联系,特别是对肝内CDS*T细胞的调节
在病毒感染期间的反应。
我们最近通过两种不同的途径(即IV和SubQ)建立了一个小鼠模型系统
感染是剖析肝内CD8+T细胞调节机制的重要系统
回应。静脉接种主要将病毒抗原输送到肝脏,而SubQ注射则表达
抗原进入淋巴结内。通过使用这种小鼠模型,我们发现腺病毒的不同途径
感染影响CDS*T细胞反应的大小和效应功能。受损的CDS*T细胞
在IV感染小鼠的肝脏中发现了反应。相比之下,感染SubQ腺病毒的小鼠
感染会产生有效的CDS*T细胞反应。此外,NKG2A*NK细胞和IL-10的产生
静脉注射Ad-LacZ感染的小鼠肝脏中的DC增加。耐人寻味的是,体内NK细胞的消耗
逆转了抗病毒CDS*T细胞反应的失调。
这些结果,再加上肝脏NK细胞的抑制功能,暗示了一种潜在的
NK细胞通过NK-DC串扰抑制CDS*T细胞效应功能的机制在这
我们将表征NK细胞在影响CDS*T细胞反应中的作用,并确定
NK介导的CDS*T细胞效应器功能受损机制这些
研究可能会提供关于NK细胞在生成过程中的调节作用的有用信息
有效的CDS*T细胞反应以及针对病毒的免疫治疗策略的新见解
感染。
英文摘要
The liver evolves mechanism(s) to dampen and possibly suppress the host immunity to nonpathogenic food
antigens. As a result, liver tropic viruses such as HCV establish the persistent infection in the liver due
impaired CD8+ T cell responses. NK cells are highly enriched in the liver and act as innate defense to viral
infection. Following conjugation between NK cells and target cells, NK cells are activated and express NK
activating/inhibitory receptors to trigger NK activity. Signaling through intimate interaction of NK
activation/inhibitory receptors is critical for controlling NK activities. NK cells have been reported to play a
pivotal role in linking innate immunity to adaptive immunity, particularly regulation of intrahepatic CDS* T cell
responses during viral infection.
We have recently established a murine model system via two different routes (i.e. IV vs SubQ) of adenovirus
infection, which is an important system to dissect the mechanism for regulation of intrahepatic CD8+ T cell
responses. IV inoculation predominantly delivers viral antigen to the liver while SubQ injection expresses
antigen into the lymph nodes. By employing this murine model, we found that different route of adenovirus
infection influence the magnitude and effector function of CDS* T cell responses. The impaired CDS* T cell
responses were found in the liver of mice following IV infection. In contrast, mice infected SubQ adenovirus
infection generates the effective CDS* T cell responses. In addition, NKG2A*NK cells and IL-10-producing
DC are increased in the liver from IV Ad-LacZ infected mice. Intriguingly, the in vivo depletion of NK cells
reversed the dysregulation of antiviral CDS* T cell responses.
These results, coupled with evidence that the inhibitory function of liver NK cells, suggest a potential
mechanism for NK cell-mediated in inhibition of CDS* T cell effector function via NK-DC cross-talk. In this
proposal, we will characterize the effect of NK cells on affecting CDS* T cell responses and determine the
mechanism for NK-mediated impairment of CDS* T cell effector function via altering DC activation. These
studies may provide a useful information regarding the regulatory role of NK cell dysregulation in generation
of effective CDS* T cell responses as well as new insights for immunotherapeutic strategies against viral
infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of HCV exosomes in intercellular communication
-
批准号:10549367
-
项目类别:
-
资助金额:$42.41万
-
财政年份:2020
-
负责人:Young S. Hahn
-
依托单位:
Role of HCV exosomes in intercellular communication
-
批准号:10833764
-
项目类别:
-
资助金额:$5.77万
-
财政年份:2020
-
负责人:Young S. Hahn
-
依托单位:
Role of HCV exosomes in intercellular communication
-
批准号:10360522
-
项目类别:
-
资助金额:$48.85万
-
财政年份:2020
-
负责人:Young S. Hahn
-
依托单位:
Control of Influenza Infection by Lipid Mediators and Macrophages
-
批准号:10317033
-
项目类别:
-
资助金额:$54.98万
-
财政年份:2018
-
负责人:Young S. Hahn
-
依托单位:
Role of HCV in aberrant APC activation/function
-
批准号:8678833
-
项目类别:
-
资助金额:$39.21万
-
财政年份:2012
-
负责人:Young S. Hahn
-
依托单位:
Role of HCV in aberrant APC activation/function
-
批准号:8468021
-
项目类别:
-
资助金额:$36.86万
-
财政年份:2012
-
负责人:Young S. Hahn
-
依托单位:
Role of HCV in aberrant APC activation/function
-
批准号:8860103
-
项目类别:
-
资助金额:$39.21万
-
财政年份:2012
-
负责人:Young S. Hahn
-
依托单位:
Role of HCV in aberrant APC activation/function
-
批准号:8371025
-
项目类别:
-
资助金额:$39.21万
-
财政年份:2012
-
负责人:Young S. Hahn
-
依托单位:
Role of HCV in aberrant APC activation/function
-
批准号:9095220
-
项目类别:
-
资助金额:$39.21万
-
财政年份:2012
-
负责人:Young S. Hahn
-
依托单位:
Regulation of CD8+ T cell responses via liver NK-DC crosstalk
-
批准号:7746094
-
项目类别:
-
资助金额:$25.51万
-
财政年份:2009
-
负责人:Young S. Hahn
-
依托单位:
Role of HCV* Hepatocyte in Regulation of Antiviral T cell Immunity
-
批准号:7919878
-
项目类别:
-
资助金额:$23.23万
-
财政年份:2005
-
负责人:Young S. Hahn
-
依托单位:
Suppression of HCV-specific CD4+ T Cells by Core Protein
-
批准号:7014423
-
项目类别:
-
资助金额:$21.05万
-
财政年份:2005
-
负责人:Young S. Hahn
-
依托单位:
Role of HCV* Hepatocyte in Regulation of Antiviral T cell Immunity
-
批准号:8712326
-
项目类别:
-
资助金额:$22.8万
-
财政年份:2005
-
负责人:Young S. Hahn
-
依托单位:
Role of HCV* Hepatocyte in Regulation of Antiviral T cell Immunity
-
批准号:8519232
-
项目类别:
-
资助金额:$19.96万
-
财政年份:2005
-
负责人:Young S. Hahn
-
依托单位:
Role of HCV* Hepatocyte in Regulation of Antiviral T cell Immunity
-
批准号:8317649
-
项目类别:
-
资助金额:$22.2万
-
财政年份:2005
-
负责人:Young S. Hahn
-
依托单位:
Role of HCV* Hepatocyte in Regulation of Antiviral T cell Immunity
-
批准号:8380559
-
项目类别:
-
资助金额:$23.14万
-
财政年份:2005
-
负责人:Young S. Hahn
-
依托单位:
Alteration of innate immunity by HCV core
-
批准号:6986137
-
项目类别:
-
资助金额:$29.65万
-
财政年份:2004
-
负责人:Young S. Hahn
-
依托单位:
Alteration of innate immunity by HCV core
-
批准号:7324055
-
项目类别:
-
资助金额:$28.24万
-
财政年份:2004
-
负责人:Young S. Hahn
-
依托单位:
Impaired T cell function by HCV core
-
批准号:6740680
-
项目类别:
-
资助金额:$30.3万
-
财政年份:2004
-
负责人:Young S. Hahn
-
依托单位:
Alteration of innate immunity by HCV core
-
批准号:7534064
-
项目类别:
-
资助金额:$28.23万
-
财政年份:2004
-
负责人:Young S. Hahn
-
依托单位:
海外基金